Glenmark Life Sciences Files IPO Papers With Sebi

Glenmark Pharmaceuticals said on Saturday that its wholly-owned arm Glenmark Life Sciences has filed preliminary papers with the market regulator Sebi for an initial public offer. The offer will comprise a fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals, Glenmark Pharma said.